Dr. Miles received a master’s degree in biology from the College of William and Mary and a Ph. D. in Biochemistry and Molecular Biology with a focus on translational control and the integrated stress response from the Indiana University School of Medicine.

Over her 25-year career at Eli Lilly, she has been recognized for leadership and implementation of genomic technologies to identify and validate new targets. She has supported small molecule, peptide, antibody, and oligonucleotide drug discovery efforts in multiple therapeutic areas including diabetes, obesity, and neurodegeneration.

AFFILIATIONS:

• Member of OTS Society 2020-2023
• Board Member OTS Society 2022-2023
• Member of the Society for Investigative Dermatology
• Scientific Advisor and Chair Midwest Symposium on Oligonucleotide Therapeutics